Mirikizumab - Intravenous (IV) trials for Crohn's disease

All Mirikizumab - Intravenous (IV) trials · All Crohn's disease trials

Phase breakdown

Recruiting trials studying Mirikizumab - Intravenous (IV) for Crohn's disease

• A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
  NCT07483073 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 140 locations
• A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
  NCT07483099 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 70 locations
• Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
  NCT06864403 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 5 locations

Common questions

How many trials study Mirikizumab - Intravenous (IV) for Crohn's disease?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.